These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 16339424)

  • 1. Infectious diseases. Will a preemptive strike against malaria pay off?
    Vogel G
    Science; 2005 Dec; 310(5754):1606-7. PubMed ID: 16339424
    [No Abstract]   [Full Text] [Related]  

  • 2. Amodiaquine, malaria, pregnancy: the old new drug.
    D'Alessandro U; ter Kuile FO
    Lancet; 2006 Oct; 368(9544):1306-7. PubMed ID: 17046445
    [No Abstract]   [Full Text] [Related]  

  • 3. Intermittent preventive treatment against malaria: an update.
    Gosling RD; Cairns ME; Chico RM; Chandramohan D
    Expert Rev Anti Infect Ther; 2010 May; 8(5):589-606. PubMed ID: 20455687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-dose sulfadoxine-pyrimethamine in intermittent preventive treatment of malaria.
    Gosling RD; Schellenberg DM; Chandramohan D
    J Infect Dis; 2006 Jun; 193(11):1609-10; author reply 1610-1. PubMed ID: 16652293
    [No Abstract]   [Full Text] [Related]  

  • 5. Intermittent preventive sulfadoxine-pyrimethamine treatment of primigravidae reduces levels of plasma immunoglobulin G, which protects against pregnancy-associated Plasmodium falciparum malaria.
    Staalsoe T; Shulman CE; Dorman EK; Kawuondo K; Marsh K; Hviid L
    Infect Immun; 2004 Sep; 72(9):5027-30. PubMed ID: 15321995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intermittent preventive treatment in infants--adjusting expectations and seeing opportunity.
    ter Kuile FO; Steketee RW
    J Infect Dis; 2006 Aug; 194(3):269-72. PubMed ID: 16826472
    [No Abstract]   [Full Text] [Related]  

  • 7. Appraisal on the prevalence of malaria and anaemia in pregnancy and factors influencing uptake of intermittent preventive therapy with sulfadoxine-pyrimethamine in Kibaha district, Tanzania.
    Tarimo SD
    East Afr J Public Health; 2007 Oct; 4(2):80-3. PubMed ID: 18085136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic constraints continue to limit coverage of intermittent preventive treatment for malaria in pregnancy in southeast Tanzania.
    Graham KJ; Ba-Break MM
    Int Health; 2013 Jun; 5(2):126-31. PubMed ID: 24030112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana.
    Clerk CA; Bruce J; Affipunguh PK; Mensah N; Hodgson A; Greenwood B; Chandramohan D
    J Infect Dis; 2008 Oct; 198(8):1202-11. PubMed ID: 18752443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment failure of falciparum malaria with Fansidar in Tawau Sabah. January-June, 1982.
    Tan Heng Soon ; Tan Puay Eng
    Med J Malaysia; 1983 Sep; 38(3):217-23. PubMed ID: 6369092
    [No Abstract]   [Full Text] [Related]  

  • 11. Sulfadoxine/pyrimethamine intermittent preventive treatment for malaria during pregnancy.
    Deloron P; Bertin G; Briand V; Massougbodji A; Cot M
    Emerg Infect Dis; 2010 Nov; 16(11):1666-70. PubMed ID: 21029522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Remarks on the drug prevention of malaria].
    Schubert S; Granz W; Kupferschmidt HG
    Z Arztl Fortbild (Jena); 1985; 79(22):957-61. PubMed ID: 4096010
    [No Abstract]   [Full Text] [Related]  

  • 13. Bigger babies for women given extra prophylaxis against malaria.
    BMJ; 2013 Feb; 346():f907. PubMed ID: 23407738
    [No Abstract]   [Full Text] [Related]  

  • 14. Placental malaria and the relationship to pregnancy outcome at Gushegu District Hospital, Northern Ghana.
    van Spronsen JH; Schneider TA; Atasige S
    Trop Doct; 2012 Apr; 42(2):80-4. PubMed ID: 22431824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
    Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
    J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermittent presumptive treatment in pregnancy with sulfadoxine-pyrimethamine: a counter perspective.
    Nosten F; McGready R
    Malar J; 2015 Jun; 14():248. PubMed ID: 26088554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of inhibition of the anti-malarial action of sulfadoxine-pyrimethamine by folic acid supplementation when used for intermittent preventive treatment in Gambian primigravidae.
    Mbaye A; Richardson K; Balajo B; Dunyo S; Shulman C; Milligan P; Greenwood B; Walraven G
    Am J Trop Med Hyg; 2006 Jun; 74(6):960-4. PubMed ID: 16760504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing malaria in pregnancy.
    Ramsay S
    Lancet Infect Dis; 2003 Jan; 3(1):4. PubMed ID: 12505015
    [No Abstract]   [Full Text] [Related]  

  • 19. Intermittent preventive treatment for malaria in infants: moving forward, cautiously.
    Breman JG; O'Meara WP
    J Infect Dis; 2005 Dec; 192(11):1869-71. PubMed ID: 16267756
    [No Abstract]   [Full Text] [Related]  

  • 20. Mathematical model for optimal use of sulfadoxine-pyrimethamine as a temporary malaria vaccine.
    Dembele B; Friedman A; Yakubu AA
    Bull Math Biol; 2010 May; 72(4):914-30. PubMed ID: 19908101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.